Coverage from the
American Diabetes Association (ADA) 2021
Read clinically focused news coverage of key developments from ADA 2021
Conference Report
Testosterone Therapy for Hypogonadism With Diabetes?
Conference Report
New Agents for Youth-Onset Type 2 Diabetes 'Finally in Sight'
Conference Report
Insulin-Pramlintide Combo Improves Type 1 Diabetes Control
Continue Reading Below
Conference Report
Anti-VEGF injections for diabetic retinopathy linked to mortality risk
Conference Report
What's Best for Diabetes After Metformin? GRADE Outdated at Outset
Conference Report
ADA 2021 — T2D: tirzepatide vs semaglutide as an add-on to metformin
Conference Report
ADA 2021 — Unmanaged diabetes tied to poor COVID-19 outcomes
Conference Report
AMPLITUDE-O: Efpeglenatide Benefits in High-Risk Diabetes
Continue Reading Below
Conferences
